Guardant Health, Inc.

NasdaqGS:GH

Market Cap

USD 5.92 B

Share Price

USD 47.81

Avg Daily Volume

2,290,005

Change (1 day)

-0.58%

Change (1 year)

41.32%

Change (YTD)

56.50%

Guardant Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2025: -51.40%

Guardant Health, Inc. EBITDA Margin is -51.40% for the Trailing 12 Months (TTM) ending March 31, 2025, a -25.08% change year over year. EBITDA Ratio is the proportion of Earnings Before Interest, Taxes, Depreciation, and Amortization to total revenue, assessing a company's operational profitability before non-operating expenses and non-cash charges.
  • Guardant Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2024 was -68.61%, a -46.80% change year over year.
  • Guardant Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2023 was -128.96%, a 35.03% change year over year.
  • Guardant Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2022 was -95.51%, a -3.98% change year over year.
  • Guardant Health, Inc. EBITDA Margin for the Trailing 12 Months (TTM) ending March 31, 2021 was -99.46%, a 285.57% change year over year.
Key Data
Date EBITDA Margin Net Income Margin EBT Margin Operating Income Margin